Home
About
Product
magNews
Career
Contact Us
中文
English
magNews
Corporate
Industry
Technology
Medical Updates
Corporate
Redefining New Boundaries in Delivering Patient Care
2025-01-24
Corporate
magAssist Recognized in 2024 VENTURE50 Awards
2025-01-09
Corporate
MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China
2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
Conference
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE
2023-06-17
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum
2023-01-16
Technology
2022 Critical Heart Disease Congress (CHDC·2022) | “BreathMo® - An Ultra-portable ECMO System” by Dr. Chia Hao Hsu from magAssist Inc.
2023-01-06
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device”
2023-01-06
Corporate
Highlights|magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application
2022-12-12
Technology
magAssist participation in the 9th World Congress of Biomechanics 2022
2022-07-10
Technology
magAssist receives keen international attention at the 47th European Society for Artificial Organs Congress
2021-09-13
Industry
The Future Belongs To Those Who Prepare For It Today| Polin Hsu of magAssist on Entrepreneurial Insights
2021-05-25
1
2
1/2
》
Tags:
Innovation,
Application,
Extra-VAD,
U.S. FDA,
Interventional Ventricular Assist Device,
Breakthrough Device,
VENTURE50,
Awards,
Healthcare,
Difference,
TOP